Target intelligence / Profile preview

NAD-dependent protein deacetylase sirtuin family (SIRT) (SIRT)

Target
SIRT
Molecular classification
Enzyme, NAD-dependent protein deacetylase, Class III histone deacetylase (HDAC), ADP-ribosyltransferase, Deacylase
01

Overview

The sirtuin family consists of seven highly conserved NAD+-dependent enzymes (SIRT1–SIRT7) that function as critical metabolic sensors and regulators of cellular health (Imai & Guarente, 2014, PMID: 24766830). By removing acetyl groups from various proteins, sirtuins coordinate the cellular response to nutrient availability and environmental stress, influencing processes such as mitochondrial function, DNA repair, and longevity (Bonkowski & Sinclair, 2016, PMID: 27882448). SIRT1, SIRT6, and SIRT7 are primarily nuclear, while SIRT3, SIRT4, and SIRT5 are mitochondrial, and SIRT2 is predominantly cytoplasmic (UniProt Consortium, 2023). These enzymes link the metabolic state of the cell, specifically the NAD+/NADH ratio, to the epigenetic and post-translational regulation of key transcription factors (Imai & Guarente, 2014, PMID: 24766830). Their involvement in age-related pathologies makes them attractive targets for drug development, with SIRT1 activators being explored for metabolic and neurodegenerative diseases (Grabowska et al., 2017, PMID: 28410500). Conversely, certain sirtuin inhibitors are being investigated for their potential anti-cancer applications due to the role of sirtuins in promoting survival in stressed tumor cells (Grabowska et al., 2017, PMID: 28410500). The therapeutic challenge lies in achieving isoform specificity and understanding the complex, often tissue-specific, roles these enzymes play in human physiology. Overall, the sirtuin family represents a pivotal bridge between metabolism and cellular maintenance, offering a unique pathway for therapeutic intervention in chronic diseases.

Other names
Silent information regulatorSIRT familyClass III histone deacetylasesNAD-dependent deacetylasesSIR2-like proteins
02

Mechanism of action

Sirtuins catalyze the NAD+-dependent deacetylation of lysine residues on histone and non-histone protein substrates, producing nicotinamide and O-acetyl-ADP-ribose as byproducts (UniProt Consortium, 2023). This activity modulates the function of key regulatory proteins involved in metabolism, DNA repair, and cell survival, such as p53, PGC-1alpha, and NF-kappaB (Imai & Guarente, 2014, PMID: 24766830). Some members also exhibit additional enzymatic activities, including ADP-ribosyltransferase, desuccinylase, and demalonylase functions, which further expand their regulatory influence over cellular pathways (UniProt Consortium, 2023).

03

Biological functions

Metabolism and energy homeostasisAging and longevity regulationDNA repair and genomic stabilityApoptosis and cell survivalGene expression regulation (Epigenetics)Mitochondrial biogenesis and functionCircadian rhythm regulationStress response
04

Disease associations

CancerNeurodegenerative disease (Alzheimer's, Parkinson's, Huntington's)Type 2 diabetes and insulin resistanceCardiovascular disease (Atherosclerosis, Heart failure)Metabolic syndrome and obesityChronic inflammationAge-related macular degeneration
05

Safety considerations

Context-dependent role in cancer, where sirtuins can act as either tumor suppressors or oncogenes depending on the tissue and stage of disease (Grabowska et al., 2017, PMID: 28410500).Potential for off-target effects due to high structural homology between the seven sirtuin isoforms, which may lead to unintended physiological consequences.Risk of metabolic disturbances when modulating enzymes that act as primary energy sensors and regulators of NAD+ homeostasis.Limited clinical translation of early sirtuin-activating compounds (STACs) due to challenges with bioavailability, potency, and target specificity (Bonkowski & Sinclair, 2016, PMID: 27882448).
06

Interacting drugs

Resveratrol

7 more in the full profile.

07

Biomarkers

Intracellular and plasma NAD+ levels (Imai & Guarente, 2014, PMID: 24766830)Acetylation status of p53 at Lys382 (Grabowska et al., 2017, PMID: 28410500)Acetylation status of Histone H3 Lysine 9 (H3K9ac)PGC-1alpha acetylation and activation levels (Bonkowski & Sinclair, 2016, PMID: 27882448)FOXO1 and FOXO3 acetylation status

Beyond the preview

Go deeper on NAD-dependent protein deacetylase sirtuin family (SIRT) (SIRT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NAD-dependent protein deacetylase sirtuin family (SIRT) (SIRT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call